Feb 06, 2020 / 09:30PM GMT
Patrick O'Brien - Ligand Pharmaceuticals Incorporated - SVP of IR
Welcome to Ligand's Fourth Quarter and Full Year 2019 Financial Results and Business Update Conference Call. Speaking today for Ligand are John Higgins, CEO; Matt Foehr, COO; and Matt Korenberg, CFO. We will be using slides to guide our discussion today that are located on our website under the IR calendar section of the website, I know it's not easy to find, we're working on fixing that, but for today, that's where you'll be able to get to them.
We will also be using non-GAAP financial measures and some of our statements will be forward-looking. Additional information concerning risk factors and other matters concerning Ligand can be found in our Ligand's earnings press release, the slides associated with today's call and our periodic filings with the SEC.
Ligand undertakes no obligation to revise or update any statements to reflect events or circumstances after the date of this conference call.
I will now turn the call over to John Higgins.
John L. Higgins - Ligand
Q4 2019 Ligand Pharmaceuticals Inc Earnings Call Transcript
Feb 07, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers